Michael Rusche is a Gastroenterology physician affiliated with Digestive Care. OpenAlex indexes 11 publications with 358 citations (h-index 4).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3800 Venetian Way
Ste 200
Newburgh, IN 476308257
Telephone
812-477-6103Provider last certified this registry record 25 Oct 2021.
Industry payments
11 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Janssen Biotech, Inc.Program year20252 payments
- ABBVIE INC.Program year20255 payments
- Celgene CorporationProgram year20245 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
57.9%Proton pump inhibitor41.2%Pantoprazole Sodium57%Omeprazole31%Esomeprazole Magnesium7%Lansoprazole6%Part D<11 patientsAminosalicylate4.1%Mesalamine100%Part D<11 patients+ 5 more classes in this area
Blood & clotting
24.6%Solutions for parenteral nutrition24.6%Peg 3350-Electrolyte100%Part D≥147 patientsCancer & immunology
15.4%Interleukin-12 Antagonist8.9%Stelara100%Part D<11 patientsInterleukin-23 Antagonist4.1%Skyrizi On-Body100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- S2097 Persistent Abdominal Pain Linked to Tuberculous Colitis
The American Journal of Gastroenterology
2022 - Incidence and predictors of “late” recurrences after endoscopic piecemeal resection of large sessile adenomas
Gastrointestinal Endoscopy
2009 - Endoscopic Resection of 107 Large Sessile Polyps: Outcome and Predictors of Cure
Gastrointestinal Endoscopy
2008 - Negative Scar Biopsy after Large Polypectomy at 3 Months Predictive of Cure
The American Journal of Gastroenterology
2005 - Infliximab in the management of rectovaginal fistulous Crohn?s disease
The American Journal of Gastroenterology
2001
Similar KOLs
Other experts from the same institution or the same specialty.
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”